New hope for dialysis patients: TS-172 targets dangerous phosphate buildup
NCT ID NCT07548840
First seen May 08, 2026 · Last updated May 22, 2026 · Updated 3 times
Summary
This study tests a new medicine called TS-172 in 30 adults with high phosphate levels who are on hemodialysis (kidney machine) three times a week. The goal is to see if TS-172 can help bring phosphate levels down to a safer target. Participants will take the drug alongside their current phosphate-lowering treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERPHOSPHATEMIA PATIENTS ON HEMODIALYSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Taisho selected site
RECRUITINGTokyo, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.